CC — Chemours Co Income Statement
0.000.00%
Last trade - 00:00- $1.92bn
- $5.46bn
- $5.78bn
- 37
- 74
- 55
- 57
Annual income statement for Chemours Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 4,969 | 6,345 | 6,794 | 6,027 | 5,782 |
| Cost of Revenue | |||||
| Gross Profit | 1,067 | 1,381 | 1,616 | 1,306 | 1,151 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 4,624 | 5,690 | 6,015 | 6,273 | 5,442 |
| Operating Profit | 345 | 655 | 779 | -246 | 340 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 179 | 676 | 741 | -318 | 127 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 219 | 608 | 578 | -237 | 86 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 219 | 608 | 578 | -238 | 86 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 219 | 608 | 578 | -238 | 86 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.88 | 4.49 | 4.71 | 1.98 | 1.05 |
| Dividends per Share |